For instance, Jisheng et al. found that in pancreatic cancer, miR-361-3p can activate the ERK pathway by targeting DUSP2, inducing EMT in pancreatic cancer cells and ultimately promoting metastasis [36]. Here, DUSP2 is linked to pancreatic neoplasm.